☆ 4.8 Review

Multiple Sclerosis

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Get Full Text
Add to Collection

Journal

NEW ENGLAND JOURNAL OF MEDICINE
Volume 378, Issue 2, Pages 169-180

Publisher

MASSACHUSETTS MEDICAL SOC
DOI: 10.1056/NEJMra1401483

Keywords

-

Categories

Medicine, General & Internal

Funding

  1. Novartis
  2. Sanofi-Synthelabo
  3. Biogen
  4. Mallinkrodt
  5. Alexion
  6. Biogen Idec
  7. Med-Immune
  8. Teva
  9. Annexon
  10. AbbVie
  11. Merck
  12. Vaccinex
  13. Vertex
  14. Disarm Therapeutics

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.